Surrozen, Inc. Warrant

SRZNW
$0.02 0.00 (0.00%)
🚫 Surrozen, Inc. Warrant does not pay dividends

Company News

Surrozen Reports Q2 Profit on Gains
The Motley Fool • Jesterai • August 8, 2025

Biotechnology company Surrozen reported a surprising Q2 2025 net income of $39.7 million, driven primarily by non-cash gains, while continuing to advance its ophthalmology pipeline focused on Wnt pathway modulation.

SRZN

Related Companies

SRX Health Solutions, Inc.
SRX Health Solutions, Inc.
SRXH
Surrozen, Inc. Common
Surrozen, Inc. Common
SRZN
SouthState Bank Corporation
SouthState Bank Corporation
SSB
Spire Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.90% Series A Cumulative Redeemable Perpetual Preferred Stock
SRpA